Brokers |
Stock Watch - 26/07/10
Investment advisor James Gerrish takes a technical look at Dow Jones, FTSE 100, S&P ASX200, WHC, AGK, WOW, FLT, WSA, NMS, BLD, BXB, ERA, MAH, AIO
|
|
|
Latest Interviews |
Stirling Products, mid year update
29 July– Stirling Products (ASX:STI), MD, Peter Boonen discusses progress with sales, re-licensing its Canadian pharmaceutical plant and its potential acquisition of TeleMedCare Holdings.
|
|
|
Major copper & gold mineralisation at Nakru 1
22 July 2010 – Coppermoly (ASX:COY), MD, Peter Swiridiuk discusses drill results, mineralisation at Nakru 1 and similarities with its Nakru 2 tenement.
|
|
|
Vietnam plant update
July 13 2010 – Hazelwood Resources ( ASX: HAZ) MD, Terry Butler-Blaxell reports that the project is on schedule and under budget with the first sales of ferrotungsten from the plant due March quarter of 2011
|
|
|
Fund manager update
13 July 2010 – John Grace, Director of Equity at fund manager Ausbil Dexia talks about the market over the last 12 months, their performance, best picks and outlook for FY 10/ 11.
|
|
|
FY end update
01 July 2010 – Rob Henderson, Chief Economist, NAB gives us an update on how the local economy is tracking at the end of the financial year.
|
|
|
SME Boardroom 12 months of operation
23 June 2010 - SME Boardroom founder, Kim Mei Li Dennis provides an update, talks about Budget outcomes for small to medium sized enterprises and plans for the year ahead.
|
|
|
Unemployment drops in May to 5.2%
11 June 2010 – St George Bank, Chief Economist, Justin Smirk explains the latest figures and provides a year-end forecast.
|
|
|
Barrick Exploration sets up at Nakru 1 ahead of drilling over next 6 months
7 June 2010 – Coppermoly (ASX:COY), MD, Peter Swiridiuk discusses progress with joint venture partner Barrick (PNG) Exploration and its recently acquired new tenements
|
|
|
Cbio Secures $12.5M funding from SpringTree
1 June 2010 – CBIO (ASX:CBZ), MD & CEO, Jason Yeates discusses the SpringTree investment, progress with the XToll trial, major pharma’s attraction to Rheumatoid Arthritis therapies and the CBIO Share Purchase Plan (SPP)
|
|
|
Secures funding for Stage 1 of processing plant in Vietnam
27 May 2010 –Hazelwood Resources (ASX:HAZ) MD, Terry Butler- Blaxwell explains its decision to process its tungsten and its choice of Vietnam for the plant.
|
|
|
Mobilarm V100 sponsorship and US Navy contract
24 May 2010 –CEO Lindsay Lyon explains its success at Seatrade Asia with its Mobilarm V100, the Global Ocean race and its trial with the US Navy.
|
|
|
RBA rate decision analysis
07 May 2010 – Su-Lin Ong, Senior Economist & Fixed Income Strategist, RBC Capital Markets, discusses the latest rate hike, provides a cash rate forecast for year end and explains the appeal of our currency and debt to international investors.
|
|
|
Kailis Organic Olive Groves to buy assets of Great Southern
04 May 2010 – MD, Mark Kailis talks about its planned acquisition of the Olive Oil assets of Great Southern, its prospectus and marketing opportunities.
|
|
|
Mobilarm to list on ASX
27 April 2010 – CEO Lindsay Lyon explains its solution to man-overboard events for marine based industry.
|
|
|
Helium project for Central Petroleum (ASX:CTP)
23 April 2010 – Central Petroleum, MD, John Heugh, explains its plans to enter the helium market.
|
|
|
Pilbara Minerals Ltd (ASX:PLS)
1 April - Pilbara Minerals Director, Mathew Walker introduces the company, its tenements and decision to raise capital.
|
|
|
NiPlats: Vanadium resource quadruples
1 April– NiPlats Australia Limited (ASX:NIP), Executive Director, Richard Wolanski talks about its Vanadium resource and 2010 plans.
|
|
|
Venture Minerals (ASX:VMS)
24 March 2010 - Venture Minerals (ASX:VMS), MD, Hamish Halliday announces an upgrade to its tin and tungsten project at Mt Lindsay, Tasmania.
|
|
|
Unilife Medical Solutions
5 November 2009 - CEO Alan Shortall talks about its safety syringes, capital raising and plans to list on NASDAQ
|
|
|
Xcelerator Premium Income Limited
28 October 2009 - Managing Director Andy Semple discusses its investment style, results and new issue
|
|
|
Hazelwood capital raising
27 October 2009 - Executive Chairman Mark McAuliffe discusses the results of its recent capital raising.
|
|
|
CBio Limited
22 October 2009 – Dr Göran Ando, Vice Chairman, Danish pharmaceutical company NovoNordisk, talks about its interest in CBio's drug XToll.
|
|
|